Evidence map›Paper›PMID 28442497›Full record

ArticleJournal of lipid research2017

An in silico model of retinal cholesterol dynamics (RCD model): insights into the pathophysiology of dry AMD.

Seyedeh Maryam Zekavat, James Lu, Cyrille Maugeais, Norman A Mazer

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Seyedeh Maryam ZekavatBiological Engineering, Massachusetts Institute of Technology, Cambridge, MA; and.
James LuDepartments of Clinical Pharmacology and Neuroscience, Ophthalmology, and.
Cyrille MaugeaisRare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Norman A MazerDepartments of Clinical Pharmacology and Neuroscience, Ophthalmology, and. Electronic address: norman.mazer@roche.com.
Massachusetts Institute of Technology · USRoche (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed an in silico mathematical model of retinal cholesterol (Ch) dynamics (RCD) to quantify the physiological rate of Ch turnover in the rod outer segment (ROS), the lipoprotein transport mechanisms by which Ch enters and leaves the outer retina, and the rates of drusen growth and macrophage-mediated clearance in dry age-related macular degeneration. Based on existing experimental data and mechanistic hypotheses, we estimated the Ch turnover rate in the ROS to be 1-6 pg/mm

Indexed as

Computer SimulationBiological TransportCholesterolHumansMacular DegenerationRetinaRetinal Pigment EpitheliumRod Cell Outer SegmentCholesterolage-related macular degenerationcell/tissueeye/retinahigh density lipoprotein/metabolismlipoproteins/kineticslipoproteins/metabolismlow density lipoprotein/metabolismmacrophages/monocytesmembranestransport

Identifiers

PMID28442497
PMCPMC5496031
OpenAlexW2608652540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.